Bienville Capital Management, LLC Pfizer Inc Transaction History

Bienville Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $202,088 - $237,096	-6,365 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $191,713 - $232,577	6,365 New	6,365 $208,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $267,165 - $346,434	-8,223 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $4,326 - $4,857	117 Added 1.44%	8,223 $356,000
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $7,575 - $8,322	-202 Reduced 2.43%	8,106 $344,000
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $319,608 - $364,388	8,308 New	8,308 $363,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $254,992 - $295,826	-7,991 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $247,721 - $272,892	7,991	7,991 $285,000

3,256

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Bienville Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bienville Capital Management, LLC with notifications on news.